<< Back to podcast list Strategic Partner(s) Brian Shoichet About Dr. Brian Shoichet BSc in Chemistry from MIT, Ph.D. with Tack Kuntz at UCSF; Postdoc with Brian Matthews Brian Shoichet on the web Google Scholar Shoichet Lab Twitter Dr.

. << Back to podcast list Strategic Partner(s) Brian Bender: Computational Probes for Orphan GPCR The Brian Bender's work addresses this problem computationally. Brian Bender Dr. Brian is one of the organizers of the upcoming Transatlantic ECI GPCR Symposium . Dr. Brian Bender on the web LinkedIn Twitter ResearchGate Dr.GPCR Member Google Scholar Dr.

Brian Shoichet at UCSF.

to Scripps Research and UCSF, where he was first introduced to GPCRs and mentored by pioneers like Brian Shoichet and Ken Jacobson.

. << Back to podcast list Strategic Partner(s) Brian Arey: Discovering Signaling Bias at the FSH Receptor Brian Arey, Director of Mechanistic Pharmacology at Bristol-Myers Squibb, traces the origins of that ABOUT THE GUEST Brian Arey is Director of Mechanistic Pharmacology within the Discovery and Optimization I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. Brian Arey on the web LinkedIn ResearchGate Pubmed Dr. GPCR Ecosystem Unlock the Full Dr.

Brian Hudson About Brian Hudson Brian is a lecturer in the School of Molecular Biosciences at the University Brian Hudson on the web University of Glasgow Unlock the Full Dr.

Brian Arey on GPCR drug discovery from the inside - GPR56 mechanotransduction, the KLF2 pathway, organizational patience, and unpublished science. << Back to podcast list Strategic Partner(s) Brian Arey - Part 2: About the Guest Brian Arey is a pharmacologist and physiologist with over 25 years of pharmaceutical I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. Brian Arey on the web LinkedIn ResearchGate Pubmed Dr. GPCR Ecosystem Unlock the Full Dr.

HSP90 runs opposite programs in brain and spinal cord. Block it in the brain and antinociception collapses. Brian Blagg at Notre Dame on β-and-GRP94-selective compounds has produced proof-of-concept IV data that Brian Blagg's KU-32 actually promotes neuronal survival in diabetic peripheral neuropathy and is now "The brain always wins.

the mechanisms of action and regulation of hormones and neurotransmitters and how they might underlie brain Brian Kolbilka (1987) Dr. Frederik Leeb-Lundberg (1984) Dr. Robert Lefkowitz (1973) Dr.

properties); Pain Management Research Institute (more opioids, cannabinoids and T-type Ca channels) and Brain Focus on study of drugs and toxins on GPCR (opioid, cannabinoid receptor) and ion channel (K, Ca, TRP

Lefkowitz was awarded the Nobel Prize in Chemistry, shared with Brian Kobilka, for studies of G protein-coupled When Brian Kobilka proposed screening a genomic library, Merck's molecular biology collaborators called His second reaction, on learning he would share the prize with Brian Kobilka, was more personal. enough problems 01:15:17 The Nobel call at 5 AM: quiet relief, a pot of coffee, and one phone call to Brian Brian Kobilka . Bob doesn’t really need an introduction since his reputation precedes him.

Brian Kobilka at Stanford University at the end of 2017 for postdoctoral work. He chose Brian's lab due to his interest in studying conformational changes. John shared his experience of reaching out to and securing a position in Brian's lab. John explained the collaborative culture in Brian's lab, where individuals are encouraged to pursue projects

Brian Kobilka's lab at Stanford University, USA.

Brian Kobilka , studying the dimerization of GPCRs. Dr.

Brian Kobilka's lab at Stanford University and the SFMB laboratory at the Université Libre de Bruxelles

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

GPCR ecosystem 32:28 Q&A — preparing an episode, funding, and what's next 46:53 Recording Brian Roth "Brian throughout his career was told so many times that he should quit science.

Bryan Roth, Dr. Robert Lefkowitz, Dr. Fiona Marshall, Dr. Sam Hoare, Dr. Graciela Pineyro, Dr. Brian Kobilka, and many other amazing scientists. What is the format of the Dr.GPCR Podcast?

the beta2-adrenergic receptor (beta2AR)-G protein complex, team effort with long time collaborator Brian

Brian Kobilka , 2012 Nobel Laureate in Chemistry.

They reviewed significant early papers related to the topic, including work by Brian Roth, Terry Kenakin

Brian Kolbika of Stanford University. Join us and learn more about Dr.

. << Back to podcast list Strategic Partner(s) Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires The brain circuits governing reward, motivation, and decision making are not fixed - Her lab investigates how GPCRs modulate synaptic transmission in brain circuits involved in reinforcement A different receptor capable of achieving the same circuit-level effect in a human brain might carry doesn't have it in a human brain.

David Hodson on visualizing GLP-1 and GIP receptors in pancreatic islets and brain circuits to advance obesity. << Back to podcast list Strategic Partner(s) Visualizing GLP-1 & GIP Receptors in Islets and Brain Professor David Hodson discusses how GLP-1 and GIP receptors regulate metabolism across the pancreas and brain Why this matters How receptor distribution in islets and brain circuits shapes incretin hormone drug

how pigment dispersing factor and related GPCRs coordinate circadian clock cells in the Drosophila brain When the lab went looking for where this NPY family receptor was expressed, they assumed brain tissue "In some ways my view of neuroscience and signaling between the brain and the body is relatively narrow

Bitter taste receptors have been identified in the heart and intestine, olfactory receptors in the brain knockout mice show anti-anxiety, anti-depressant phenotypes, and expression of the receptor in the brain TAS2Rs have been identified in the heart and intestine; olfactory receptors in the brain.

examined the role of organic cation transporter 3 (OCT3) in the regulation of monoamine signaling in the brain

the mechanisms of action and regulation of hormones and neurotransmitters and how they might underlie brain

in immune cells and insulin-sensitive tissues (liver, pancreas, skeletal muscle, adipose tissue, and brain